GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (WBO:MDT) » Definitions » Cyclically Adjusted PS Ratio

Medtronic (WBO:MDT) Cyclically Adjusted PS Ratio : 3.33 (As of Dec. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medtronic Cyclically Adjusted PS Ratio?

As of today (2024-12-14), Medtronic's current share price is €78.97. Medtronic's Cyclically Adjusted Revenue per Share for the quarter that ended in Oct. 2024 was €23.71. Medtronic's Cyclically Adjusted PS Ratio for today is 3.33.

The historical rank and industry rank for Medtronic's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:MDT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.8   Med: 5.08   Max: 6.71
Current: 3.21

During the past years, Medtronic's highest Cyclically Adjusted PS Ratio was 6.71. The lowest was 2.80. And the median was 5.08.

WBO:MDT's Cyclically Adjusted PS Ratio is ranked worse than
57.67% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 2.36 vs WBO:MDT: 3.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medtronic's adjusted revenue per share data for the three months ended in Oct. 2024 was €5.994. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €23.71 for the trailing ten years ended in Oct. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medtronic Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Medtronic's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Cyclically Adjusted PS Ratio Chart

Medtronic Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.08 6.51 4.69 3.74 3.16

Medtronic Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.81 3.52 3.16 3.12 3.47

Competitive Comparison of Medtronic's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted PS Ratio falls into.



Medtronic Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medtronic's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=78.97/23.71
=3.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic's Cyclically Adjusted Revenue per Share for the quarter that ended in Oct. 2024 is calculated as:

For example, Medtronic's adjusted Revenue per Share data for the three months ended in Oct. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Oct. 2024 (Change)*Current CPI (Oct. 2024)
=5.994/121.9561*121.9561
=5.994

Current CPI (Oct. 2024) = 121.9561.

Medtronic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201501 3.733 98.779 4.609
201504 4.685 99.975 5.715
201507 4.603 100.374 5.593
201510 4.401 100.075 5.363
201601 4.490 98.879 5.538
201604 4.708 99.875 5.749
201607 4.609 100.872 5.572
201610 4.789 99.776 5.854
201701 4.950 99.178 6.087
201704 5.346 100.773 6.470
201707 4.658 100.673 5.643
201710 4.393 100.374 5.338
201801 4.463 99.377 5.477
201804 4.859 100.374 5.904
201807 4.629 101.470 5.564
201810 4.782 101.271 5.759
201901 4.887 100.075 5.956
201904 5.364 102.068 6.409
201907 4.944 101.969 5.913
201910 5.155 101.969 6.165
202001 5.145 101.371 6.190
202004 4.088 101.969 4.889
202007 4.193 101.570 5.035
202010 4.807 100.474 5.835
202101 4.707 101.171 5.674
202104 5.041 103.065 5.965
202107 4.982 103.763 5.856
202110 4.991 105.557 5.766
202201 5.082 106.255 5.833
202204 5.574 110.242 6.166
202207 5.430 113.262 5.847
202210 5.780 115.315 6.113
202301 5.383 114.470 5.735
202304 5.847 118.213 6.032
202307 5.220 119.903 5.309
202310 5.677 121.111 5.717
202401 5.576 119.179 5.706
202404 6.048 121.232 6.084
202407 5.629 122.560 5.601
202410 5.994 121.956 5.994

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medtronic  (WBO:MDT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medtronic Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Medtronic's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medtronic Business Description

Address
Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.